• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征女性血清人附睾蛋白4水平的评估

Evaluation of Serum Human Epididymis Protein 4 Levels in Women with Polycystic Ovary Syndrome.

作者信息

Hancerliogullari Necati, Tokmak Aytekin, Kuru Pekcan Meryem, Oksuzoglu Aysegul, Candar Tuba, Ustun Yaprak

机构信息

Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, TUR.

Obsterics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, TUR.

出版信息

Cureus. 2019 Sep 24;11(9):e5736. doi: 10.7759/cureus.5736.

DOI:10.7759/cureus.5736
PMID:31723497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6825455/
Abstract

Aim The main purpose of this study is the determination of serum epididymis protein 4 (HE4) levels in women diagnosed with polycystic ovary syndrome (PCOS) and comparison with non-PCOS healthy controls. Methods All consecutive women, who applied between January 2017 and June 2017 to the gynecology outpatient clinics at the Zekai Tahir Burak Women's Health Training and Research Hospital and met the study criteria, were included in this cross-sectional study. Serum human epididymis protein 4 (HE4) concentrations were measured in each woman and the mean values were compared between the PCOS and non-PCOS groups. Results A total of 90 women (45 with PCOS and 45 without PCOS) were included in the final analysis. There were no statistically significant differences between the groups in terms of age and body mass index ( >0.05). Basal serum HE4 levels were 172.8 ± 139.8 and 131.8 ± 123.1 pmol/L in the PCOS and non-PCOS groups, respectively ( = 0.415). Conclusion The serum HE4 levels were found to be similar in women with and without PCOS. No significant correlation was observed between PCOS parameters and serum HE4 levels.

摘要

目的 本研究的主要目的是测定诊断为多囊卵巢综合征(PCOS)的女性血清附睾蛋白4(HE4)水平,并与非PCOS健康对照进行比较。方法 纳入2017年1月至2017年6月期间连续到泽凯·塔希尔·布拉克妇女健康培训与研究医院妇科门诊就诊且符合研究标准的所有女性,进行这项横断面研究。测定每位女性血清人附睾蛋白4(HE4)浓度,并比较PCOS组和非PCOS组的平均值。结果 最终分析共纳入90名女性(45名PCOS患者和45名非PCOS患者)。两组在年龄和体重指数方面无统计学显著差异(>0.05)。PCOS组和非PCOS组的基础血清HE4水平分别为172.8±139.8和131.8±123.1 pmol/L(P = 0.415)。结论 发现PCOS患者和非PCOS患者的血清HE4水平相似。未观察到PCOS参数与血清HE4水平之间存在显著相关性。

相似文献

1
Evaluation of Serum Human Epididymis Protein 4 Levels in Women with Polycystic Ovary Syndrome.多囊卵巢综合征女性血清人附睾蛋白4水平的评估
Cureus. 2019 Sep 24;11(9):e5736. doi: 10.7759/cureus.5736.
2
Clomiphene Citrate Treatment Cycle Outcomes of Polycystic Ovary Syndrome Patients Based on Basal High Sensitive C-Reactive Protein Levels: A Cross-Sectional Study.基于基础高敏C反应蛋白水平的多囊卵巢综合征患者枸橼酸氯米芬治疗周期结局:一项横断面研究
Int J Fertil Steril. 2017 Jan-Mar;10(4):320-326. doi: 10.22074/ijfs.2016.4849. Epub 2016 Nov 1.
3
Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.多囊卵巢综合征合并1型糖尿病女性的血清抗苗勒管激素浓度
Metabolism. 2016 May;65(5):804-811. doi: 10.1016/j.metabol.2016.02.005. Epub 2016 Feb 16.
4
The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.非肥胖、非高雄激素多囊卵巢综合征患者血清和卵泡内胰岛素抵抗参数及同型半胱氨酸水平对体外受精结局的影响。
Fertil Steril. 2010 Apr;93(6):1864-9. doi: 10.1016/j.fertnstert.2008.12.024. Epub 2009 Jan 26.
5
[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[多囊卵巢综合征女性与育龄期健康女性的血清抗苗勒管激素水平]
Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23.
6
[The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].[血清人附睾分泌蛋白4及CA125检测在卵巢恶性肿瘤诊断中的价值]
Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):931-6.
7
The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.血清抗苗勒管激素与多囊卵巢形态和多囊卵巢综合征的关系:一项前瞻性队列研究。
Hum Reprod. 2013 Apr;28(4):1077-83. doi: 10.1093/humrep/det015. Epub 2013 Feb 1.
8
Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.多囊卵巢形态学与多囊卵巢综合征的诊断:应用聚类分析重新定义卵泡计数和血清抗苗勒管激素的临界值。
Hum Reprod. 2017 Aug 1;32(8):1723-1731. doi: 10.1093/humrep/dex226.
9
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.根据鹿特丹标准与包括抗苗勒管激素在内的修订标准,正常人群中多囊卵巢综合征的患病率。
Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16.
10
[A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].基于2012年中国多囊卵巢综合征诊断标准的血清抗苗勒管激素在多囊卵巢综合征诊断中的初步研究
Zhonghua Fu Chan Ke Za Zhi. 2015 Nov;50(11):819-24.

本文引用的文献

1
Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.多囊卵巢综合征与卵巢癌的遗传关联:一项孟德尔随机化研究。
Int J Epidemiol. 2019 Jun 1;48(3):822-830. doi: 10.1093/ije/dyz113.
2
Polycystic ovary syndrome and risk of endometrial cancer: a mini-review.多囊卵巢综合征与子宫内膜癌风险:一篇综述短文
Asian Pac J Cancer Prev. 2014;15(17):7011-4. doi: 10.7314/apjcp.2014.15.17.7011.
3
HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review.健康个体以及良性或恶性肿瘤患者中HE4的组织表达和血清HE4水平:一项系统综述
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2285-95. doi: 10.1158/1055-9965.EPI-14-0447. Epub 2014 Aug 28.
4
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征女性的子宫内膜癌、卵巢癌和乳腺癌风险:系统评价和荟萃分析。
Hum Reprod Update. 2014 Sep-Oct;20(5):748-58. doi: 10.1093/humupd/dmu012. Epub 2014 Mar 30.
5
A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents.一项关于采用稳态模型评估法胰岛素抵抗指数(HOMA-IR)及其临界值以识别印度城市青少年代谢综合征的研究。
J Clin Res Pediatr Endocrinol. 2013;5(4):245-51. doi: 10.4274/Jcrpe.1127.
6
Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovary.卵巢良、交界性及恶性病变中 HE4 的免疫组化定位。
Int J Gynecol Pathol. 2012 Nov;31(6):517-23. doi: 10.1097/PGP.0b013e31824fe269.
7
Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration.多囊卵巢综合征女性卵巢癌风险的蛋白质组学生物标志物:系统评价和生物标志物数据库整合。
Fertil Steril. 2012 Dec;98(6):1590-601.e1. doi: 10.1016/j.fertnstert.2012.08.002. Epub 2012 Sep 6.
8
Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.比较人附睾蛋白 4 与癌抗原 125 作为恶性和非恶性疾病患者的肿瘤标志物。
Clin Chem. 2011 Nov;57(11):1534-44. doi: 10.1373/clinchem.2010.157073. Epub 2011 Sep 20.
9
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.血清 HE4 检测对子宫内膜癌患者的诊断和预后影响。
Br J Cancer. 2011 Apr 26;104(9):1418-25. doi: 10.1038/bjc.2011.109. Epub 2011 Apr 5.
10
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.在对比不同诊断标准的情况下,对社区样本中多囊卵巢综合征的流行情况进行评估。
Hum Reprod. 2010 Feb;25(2):544-51. doi: 10.1093/humrep/dep399. Epub 2009 Nov 12.